Patent ID: 11857525
Assignee: SOCIETE DES PRODUITS NESTLE S.A.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating or preventing cachexia induced by at least one of surgery, cancer or infection in a patient who is an individual with bladder cancer scheduled to undergo a radical cystoprostatectomy, the method comprising administering to the patient a specialized immunonutrition supplement comprising a combination of L-arginine, omega-3 fatty acids, vitamin A, and nucleotides, and
the specialized immunonutrition supplement is administered to the patient in a daily dose that provides an amount of the omega-3 fatty acids that comprises about 0.5 g to about 10.0 g of eicosapentaenoic acid and docosahexaenoic acid in total per day and that provides at least about 500 μg RE of the vitamin A per day; and
the specialized immunonutrition supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to the radical cystoprostatectomy to a post-operative day that is three to seven days after the radical cystoprostatectomy.